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ABSTRACT 
Streptococcus agalactiae and Streptococcus uberis are relevant mastitis pathogens, a prevalent 
and costly disease in dairy herds, which have a considerable impact on cow health, in milk 
quality and production. The aim of this study was to investigate the occurrence of some 
antimicrobials-related and virulence-related genes in Str. uberis and Str. agalactiae isolated 
from bovine milk and to assess the molecular epidemiology. 
Several virulence genotypes were observed to be associated with mammary infections. These 
genotypes were found within the same herd and among different herds, showing that different 
virulence patterns were able to cause infection. The genetic variability was higher in Str. uberis, 
with the different virulence patterns being able to cause clinical mastitis and apparently none of 
the virulence genotypes seem to be dominant relative to the others. On the contrary, Str. 
agalactiae present less genetic variability.  
The genes responsible for the adherence to epithelium were present in all tested strains, the 
sua gene in Str. uberis and the fbsB gene in Str. agalactiae. Markers derived from the fructose 
operon (FO1 and FO3) were specific to bovine isolates of Str. agalactiae. The nisin operon 
markers (NU1 and NU3) were able to discriminate strain-specific patterns of Str. uberis, but 
were not found in Str. agalactiae. The virulence-associated markers (V1, V3) were detected in 
all of Str. uberis. The gapC marker (V2) was able to discriminate virulence patterns of Str. 
agalactiae, and was also possible to detect the antimicrobials resistance gene ermB in this 
species. An apparent advantage in the frequency and severity of infection for strains containing 
the gene gapC was also suggested. 
This work suggests reinforces the hypothesis from a previous study (Almeida et al., 2013) about 
the good consistency and stability of these markers to be used for identification of members of 
the Streptococcus genus, Str. agalactiae and Str. uberi. The obtained results also suggest the 
exchange of genetic material between Str. agalactiae and environmental bacteria. Finally it is 
expected that this work contributes for the implement of methodological ground to carry out 
epidemiological and molecular evaluations in causative agents of bovine mastitis. 
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DNA Deoxyribonucleic acid 
fbsA- Fibrinogen-binding protein A 
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INTRODUTION 
1. Mastitis 
Despite the control strategies, bovine mastitis remains the most important economic 
disease affecting dairy herds throughout the world. This disease influences milk 
production, increases the treatment costs and decreases milk quality reducing its 
economic value.  
Mastitis is an inflammation of the mammary gland that occurs as a response to injury. 
The inflammation process has the purpose of destroying or neutralizing the infectious 
agents allowing subsequent healing and return to normal function. Clinically It can be 
divided into clinical mastitis (symptomatic) and subclinical mastitis (asymptomatic) 
(Jones & Bailey, 2009). The inflammation can be caused by physical trauma and 
chemical irritants, but the most common causes of mastitis in dairy cows are infectious 
agents, usually bacteria but also Mycoplasma and Algae (Jones& Bailey, 2009; Ruth et 
al., 2011). Over 150 different species able to cause bovine mastitis have been 
identified, most commonly Staphylococcus, Streptococcus and Gram-negative bacteria 
including Escherichia coli. Other agents such as Mycoplasma, Enterococcus, 
pseudomonads and Algae are less frequently isolated (Watts, 1988; Ruth et al., 2011; 
Contreras & Rodriguez, 2011).  
Commonly, pathogens are found either in the udder (contagious pathogens) or in the 
cow's surroundings (environmental pathogens). The reservoir for contagious 
pathogens is the udder of an infected cow. Pathogens are then spread from infected 
udders during milking process through contaminated teatcup liners or milkers' hands, 
leading to longer and prevalent infections in herds. Environmental pathogens are 
spread from soil, cow’s bed, manure but may also be transmitted during milking. The 
risk of infection of environmental pathogens is high if the cow lies down after milking, 
since the sphincter muscles in the teat canal remain dilated. Environmental infections 
are frequently associated with an unsanitary environment and are often responsible for 
the majority of the clinical cases (Jones & Bailey, 2009; McDonald, 1979). 
Staphylococcus aureus and Streptococcus agalactiae are the contagious pathogens 
most frequently detected in mastitis isolates. On the other hand the most prominent 
environmental agents are Streptococcus uberis, Str. dysgalactiae, coliforms such as 
Escherichia coli and Klebsiella pneumonia (Jones & Bailey, 2009; McDonald, 1979). 
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2. Streptococcus  
As previously described, several streptococcal species are amongst the most 
frequently isolated udder pathogens. Streptococci are Gram-positive bacteria 
widespread in the environment and are also commensal organisms of the cow’s udder, 
mucosa and skin. Some of the commensal Streptococcus are opportunistic bacteria 
causing infection if the balance between bacteria and host is broken. Others are 
considered primary pathogens of mastitis (Sandholm et al., 1995; Cleary & Cheng, 
2006). The most significant species are Str. agalactiae (contagious agent), Str. uberis 
(environmental agent) and to a lower extent Str. bovis, Str. dysgalactiae and other 
streptococci (Kuang et al., 2009; Jones & Bailey, 2009). 
 
2.1. Streptococcus agalactiae 
Str. agalactiae belong to Group B Streptococcus (GBS), pyogenic and haemolitic 
streptococci. In humans, Str. agalactiae is a commensal organism which is best known 
as a cause of postpartum infection and a common cause of meningitis in neonates. It 
also provokes urinary tract infections, pneumonia, osteomyelitis, meningitis and soft 
tissue infections (Devi et al., 2010; Woods & Levy, 2013). In ruminants, Str. agalactiae 
is a major cause of mastitis, causing mainly subclinical infections (Katholm & 
Rattenborg, 2010). 
Str. agalactiae, such as others contagious pathogens, can be kept under control by 
preventive measures to avoid the entry of infected cows in herd, by preventing its 
spread during milking (e.g. milking the infected cows after the healthy cows) or by 
treatment and dry-cow therapy with antibiotics. In well-managed herds it is possible to 
completely eliminate Str. agalactiae (Jacobsson, 2003). Nevertheless, the 
epidemiological study of Str. agalactiae is particularly important since a single strain is 
able to infect multiple animals in a herd and the use of antibiotics in food production is 
now questioned (Jones et al., 2003). 
Infections caused by Str. agalactiae are usually asymptomatic and persistent, but 
efficiently eliminated with intramammary therapy (Keefe, 1997). However, new 
infections in the herd may lead to prevalent subclinical infections, with normal 
appearance of the milk and udder. Even though, milk production decreases and 
composition is altered (Jones & Bailey, 2009). Milk of healthy quarters generally 
contain below 200x103 somatic cells/ml. During subclinical infections the influx of 
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inflammatory cells into milk, mostly polymorphonuclear neutrophil (PMN), increases, 
resulting in an elevation of somatic cell count (SCC) which is reflected in the elevation 
of SCC in bulk tank (Jones & Bailey, 2009).  
Most of the strains are CAMP-positive (97%-99%) and approximately half of them are 
β-haemolytic (Devi et al., 2010; Sandholm et al., 1995). The differences in 
pathogenicity between strains might be related to several putative virulence factors that 
will be described later.  
 
2.2. Streptococcus uberis 
It is possible to eradicate contagious pathogens in herds, but environmental pathogens 
are ubiquitous throughout the dairy environment and improving milking hygiene is not 
enough to prevent their spread. These traits makes Streptococcus uberis particularly 
problematic considering that it is an important cause of clinical and subclinical mastitis 
in both lactating and nonlactating cows (Reinoso, et al. 2011).  
Str. uberis has been recently identified as a highly recombinant organism and some 
strains can establish infection more effectively than others (Richards et al., 2011; Pryor 
et al., 2009). The differences in pathogenicity between strains are related to several 
putative virulence factors. Among these, evasion of the host phagocytosis conferred by 
the hyaluronic acid capsule (Ward et al., 2001); ability to obtain essential nutrients to 
grow in the mammary gland environment by plasminogen activator proteins such as 
PauA (Rosey et al., 1999); adherence to and invasion of the host tissue mediated by 
SUAM (Almeida et al., 2006); CAMP factor (Jiang et al., 1996); and a surface 
dehydrogenase protein GapC (Pancholi et al., 1993), have been described (Reinoso et 
al., 2011). Furthermore, recent studies have identified a nisin U operon with close 
similarity to Str. agalactiae, which has been suggested to provide a competitive 
advantage during mastitis infection (Richards et al., 2011). Most of the strains are 
CAMP-negative, but CAMP-positive strains also can be found (Sandholm et al., 1995). 
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3. Udder defence 
The udder has two defensive mechanisms: the primary defence mechanisms prevent 
the pathogenic agents from entering the mammary gland, and the secondary defence 
mechanisms consist in several immunological, chemical and cellular systems in milk. 
The teat canal serves as the udder first line of defence. It represents a physical barrier 
to the invasion of microorganisms, nevertheless the sphincter muscle in the teat canal 
remains dilated for approximately two hours after milking and the risk of ascending 
infection is high during this period. The use of a teat dipping after milking and 
preventing cows from lying down during this critical period are measures that reduce 
considerably the risk of ascending infections (Sandholm et al., 1995; Jones & Bailey, 
2009). When microorganisms invade the teat canal, the washing-out effect of milking 
and the epithelial desquamation are mechanisms that decrease bacterial colonization 
(Sandholm et al., 1995). Moreover, the epithelial cells produce keratin, a fibrous protein 
with long chain fatty acids that present bacteriostatic properties (Jones & Bailey, 2009). 
If the microorganisms pass through the first line of the udder defence, milk is not a 
good environment for bacterial growth due to the presence of antimicrobial factors in 
the udder secretion. The concentrations of these factors are under genetic control and 
depend on the udder health and lactation stage. Briefly, the most significant 
antibacterial factors of milk are Lactoferrin, Transferrin, Lysozyme, Lactoperoxidase, 
the complement system and the immunological defence mechanisms. (Sandholm et 
al., 1995) 
The iron binding proteins like Lactoferrin and Transferrin are a significant part of 
antibacterial defence. They are detected at relatively high concentrations in milk and 
during mastitis the concentration of these proteins in bovine mammary secretions 
greatly increases. They counteract the iron uptake by the bacteria and thus prevent 
bacterial growth. However, streptococci in general are less sensitive to the iron 
restriction because they have low iron requirement (Sandholm et al., 1995; Fang & 
Oliver, 1999). Lysozyme is an antimicrobial enzyme which hydrolyses the β-glycosidic 
linkage between muramic acid and N-acetylglucosamine in the peptidoglycan structure 
of the bacterial wall, causing osmotic lysis of the bacteria. Nevertheless, the 
bacteriolytic effect in milk is weak due to his low concentration (Sandholm et al., 1995). 
The Lactoperoxidase causes an oxidation of sensitive enzymes within the bacterial cell 
wall and it is effective against Str. uberis infections. Lactoperoxidase also prevents Str. 
agalactiae infections at some degree. However, the activity of Lactoperoxidase is 
limited by the concentration of peroxide. The oxygen pressure in milk is low, and 
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decreases more during inflammation, which inhibits the formation of peroxidase and 
limits the Lactoperoxidase activity during mastitis (Sandholm et al., 1995). The 
complement system recognizes and destroys bacteria, particularly important against 
E.coli infections, and helps bacterial opsonisation by phagocytes (Sandholm et al., 
1995). 
The immunological response is influenced by many factors, such as the immune and 
nutritional status of the cow, stage of lactation, age and the causative pathogen 
(Harmon, 1994). During mammary infection PMN leukocytes and phagocytes are 
attracted in large numbers into milk, thus increasing the somatic cell count (SCC) as 
well as damaging secretory cells. Somatic cells consist mainly of PMN and white blood 
cells. Substances released by PMN completely destroy the alveolar structure which is 
replaced by scar tissue. This process may conduct to the occurrence of small focus of 
infection walled of scar tissue that becomes difficult to reach with antibiotics (Jones & 
Bailey, 2009). 
 
4. Factors in Bacteria Promoting Infection 
The infection of mammary glands occurs when bacteria invade the teat canal and 
spread towards the upper milk tract. The severity of infection depends on the 
adaptation to the milk environment and on various virulence factors (Sandholm et al., 
1995). Despite the large range of bacteria present in the dairy environment, usually 
only one strain is isolated within the same mammary quarter (or at most two) and 
infections with multiple strains are rare (Pryor et al., 2009). 
To occur an infection may not be enough for bacteria to penetrate the udder defence 
as other bacterial species may also entry to mammary gland and compete with each 
other to become the dominant species. The selection of a dominant species is linked to 
several bacterial factors. Among these, the ability to adhere to and invade epithelial 
cells; to avoid the bovine immune system or to resist phagocytosis and the ability to 
obtain essential nutrients to growth in milk seems to play an important role. Within the 
same species direct competition between different strains can also occur through the 
production of small antimicrobial peptides and bacteriocins, which destroy bacteria of 
the same or closely related species (Pryor et al., 2009). The characterization and study 
of these factors could give some information about the strains of Str. agalactiae and 
Str. uberis more adapted to mammary gland environment and be the dominant species 
in mastitis. The factors that were investigated in this work are described below. 
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4.1. Adherence and invasion 
Bacteria causing chronic mastitis are able to adhere to the mamary gland tissue and 
resist to the milk flow. Furthermore, the virulence of bacteria is diminished when the 
adherence factors are not present (Sandholm et al., 1995). Bacterial adherence to the 
host via its surface adhesins is considered important during early stages of infection in 
Str. agalactiae and Str. uberis, since it prevents the flushing effect during milking and 
reduces the effectiveness of phagocytic defences (phagocytes cannot reach the 
intracellular environment) (Jacobsson et al., 2003; Prado et al., 2010). 
A subfamily of these adhesins known as Microbial Surface Component Recognizing 
Adhesive Matrix Molecules, binds specifically to extracellular matrix molecules like 
fibrinogen, fibronectin, laminin and collagen (Patti et al., 1994). These molecules are 
located in the intercellular tissue bellow the epithelium. Consequently, epithelial lesions 
promote the adherence of the bacteria (Sandholm et al., 1995). 
Fibrinogen (Fg) is frequently a site of binding among the Gram-positive bacteria. In Str. 
agalactiae two subfamilies of proteins that bind to Fg have been studied: Fibrinogen-
binding protein A (FbsA) and Fibrinogen-binding protein B (FbsB) (Devi et al., 2010). 
The FbsA promotes binding of Str. agalactiae to the human Fg (Schubert et al., 2002). 
The FbsB has a conserved C-terminal region and N-terminal signal peptide. The region 
between the N-terminal peptide and C-terminal differs from one strain to other and this 
non-conserved region can bind Human Fg. However, it has been shown that the 
conserved C-terminal region (fbsB[C]) binds only to bovine Fg (Jacobsson et al., 2003 
and Gutekunst et al, 2004). Furthermore, milk has high calcium content and the 
presence of Ca2+ increases the FbsB[C] binding to bovine Fg (Devi et al, 2010). Some 
studies have demonstrated that FbsB also promotes the invasion of S. agalactiae into 
lung epithelial cells (Gutekunst et al, 2004). Nevertheless, its role in invasion of 
mammary epithelial cells in cows remains unknown and requires future studies.  
The adherence of Str. uberis takes a different pathway. The Streptococcus uberis 
adhesion molecule (Suam), also called previously as lactoferrin-binding protein (Fang 
& Oliver, 1999), has high affinity to lactoferrin and is involved in the adherence and 
invasion of bovine mammary epithelial cells in Str. uberis (Almeida et al., 2006).  
Lactoferrin is an iron binding protein, with low antibacterial effect against Str. uberis 
(streptococci have low requirement for iron), which is present at high concentrations in 
milk. Its main function is to counteract the iron uptake by the bacteria. However, in 
addition to the binding iron ability, Lactoferrin also binds to cellular membranes of 
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mammary epithelial cells, working as a bridging protein between Str. uberis and 
epithelial or phagocytes cells in the adhesion process (Fang & Oliver, 1999).  
4.2. Capsule 
Some pathogenic bacteria protect themselves against phagocytosis with intracellular 
growth, destruction of phagocytes and avoidance of the host cellular defences. In 
capsulated S. aureus and E. coli the antibodies and complement factors cannot reach 
the bacteria, impairing the recognition of the pathogen by phagocytes (Sandholm et al., 
1995). The mechanism of hyaluronic acid capsule to avoid phagocytosis is not totally 
clear for Str. uberis, and contrary to S. aureus, the amount of immunoglobulin bounds 
was not affected by the presence of capsule (Leight et al., 1994). Nonetheless, the 
strains that have an hyaluronic capsule around them appear to be resistant to 
phagocytosis by bovine neutrophils and establish infection more effectively (Ward et 
al., 2001; Leight, et al., 1991). Moreover, these bacteria tolerate better the LP system, 
causing persistent infections (Sandholm et al., 1995).  However, recent studies 
reported that the hyaluronic acid capsule of Str. uberis seems to plays a minor role in 
the early stages of the infection with the resistance to phagocytosis being ascribed to 
an undefined component unconnected with the capsular phenotype (Ward et al, 2009). 
A cluster of tree genes is involved in the production of the hyaluronic acid capsule: 
hasA, hasB and hasC (Ward et al., 2001).  The gene hasA catalyzes the hyaluronic 
acid from N-acetylglucosamine and glucuronic acid (DeAngelis et al., 1993), hasB 
encondes UDP-glucose dehydrogenase (Dougherty et al., 1993) and hasC encodes 
UDP-glucose pyrophosphorylase (Ashbaugh et al., 1998). 
4.3. Fructose operon 
Carbohydrates are an important source of carbon and energy for the growth of many 
bacteria. When grown in an environment with different carbon sources namely glucose, 
lactose and fructose, bacteria preferentially utilize only one class of carbohydrates, 
usually glucose. In the absence of the primary source of carbon, the cAMP 
concentration increases and forms a complex with CAP, the cAMP-CAP complex. This 
cAMP-CAP complex increases the expression of CAP-dependent operons, including 
some enzymes that can supply energy from lactose and fructose (Chu et al., 
1999).Recent studies have shown that the complete fructose operon is present in most 
of bovine Str. agalactiae and is absent in all human strains. This suggests a unique 
fructose utilization pathway for bovine strains of Str. agalactiae, and may facilitate 
survival in nutritionally limited environments, surviving longer in extrammary reservoirs 
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(Richards et al., 2011). A four-gene operon is involved in fructose utilization: 
phosphotransferase system fructosespecific IIA component (fruD), fructose-specific 
IIBC PTS component (fruC), fructose-1-phosphate kinase (fruP) and transcriptional 
regulator (fruR) (Richards et al., 2011). 
4.4. Obtaining essential nutrients to grow in milk  
Extracellular proteins are commonly related to pathogenicity. These proteins facilitate 
the bacterial growth and protect them from the immune system. Some authors have 
associated the presence of one of these proteins, the Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) protein as a virulence factor for Str. uberis and Str. 
agalactiae (Ling et al, 2004; Maeda et al., 2004; Reinoso et al., 2011). This enzyme is 
involved in bacterial energy production, breaking down glucose for energy and carbon 
molecules which is essential for bacterial growth in environments without 
neoglucogenic substrates (Madureira et al., 2007; Kim et al., 2005). Furthermore, 
besides the immunomodulatory properties, has been reported that GAPDH has the 
ability to bind to several host proteins and to resist against reactive oxygen produced 
by phagocytic cells. Moreover, it has imunomodulatory properties (Madureira et al., 
2007; Holzmuller et al., 2006; Pancholi & Fischetti, 1992).  
Str. uberis is a fastidious organism unable to grow in media where the amino acid 
composition consists only of those found in free or peptide form in milk. Therefore, to 
grow in milk this bacterium must be able to hydrolyse milk proteins (Kitt and Leigh 
1997; Leigh et al., 1993; Smith et al., 2002). The hydrolysis of plasminogen to plasmin, 
through extracellular plasminogen activator (PauA), is an important route to facilitate 
the acquisition of amino acids and peptides essential for bacterial growth. However, for 
the acquisition and accumulation of amino acids internally an intact oligopetide 
transport system it is necessary. Without this system bacterial growth in milk may not 
be possible. These bacterial oligopepide permeases (opps) have been identified in 
several streptococci species, comprising a complex of five proteins: oppA, oppB, oppC, 
oppD and oppF. Among them, the oppF, which provides energy for transport of the 
peptide substrate, seems to play an important role during growth of Str. uberis in milk 
(Smith et al., 2002; Reinoso et al., 2011). 
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4.5. Nisin U operon 
Many Gram-positive bacteria are capable of producing a broad range of molecules that 
may be inhibitory either to themselves or to other bacteria. Some of these bacterial 
toxins are categorized as bacteriocins, i.e. antimicrobial peptides that typically inhibit 
the growth of the same or closely related species (Jack et al., 1995; Pryor et al., 2009). 
Within the streptococcal mastitis, nisin is the most widely studied bacteriocin and a new 
variant of nisin was discovered in Str. uberis: the nisin U (Wirawan et al., 2006).  
Studies conducted in experimentally infected cows with multiple strains of Str. uberis 
showed that, when infused alone, all the strains were capable of causing mastitis. 
However, when infused together, a single nisin U producer strain usually predominated 
in intramammary infection. These results indicate that multiple strains can be reduced 
to only one strain during development of infection and suggest that the ability to 
produce nisin U may have provided these strains with a competitive advantage during 
infection (Pryor et al., 2009). Interestingly, only a few strains of Str. uberis seem to 
possess the ability to produce nisin (Wirawan et al., 2006). 
Lateral transference of genes mediated via integrative conjugative elements may occur 
between Streptococcus species (Davies et al., 2009), and it is possible that the nisin U 
operon was laterally exchanged between Str. uberis and Str. agalactiae (Richards et 
al., 2011). In theory, Str. agalactiae strains containing the nisin U operon might have a 
similar advantage during infection. Although, none of Str. agalactiae strains possessing 
the nisin operon studied by Richards et al. (2011), could produce nisin. Nonetheless, it 
is possible that some bovine Str. agalactiae may possess functional nisin operons 
providing them a similar competitive advantage during mastitis infection (Richards et 
al., 2011). Also the nisin U operon is not present in Str. agalactiae human strains 
indicating that this specificity to bovine strains is correlated with a bovine environment 
(Richards et al., 2011).  
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5. Resistance to antimicrobials 
The widespread use of antimicrobials for prevention and treatment of dry-cow and 
clinical mastitis resulted in an overall increase in resistance of mastitis pathogens to 
these components (Erskine et al., 2004). The choice of antimicrobial products for 
mastitis treatment depends on the availability and regulation of veterinary drugs and 
differs across countries. Many antimicrobials are authorized for mastitis treatment in 
cattle, namely penicillin, cefazolin, cefoperazone, pirlimycin, gentamicin, streptomycin 
and amoxicillin–clavulanic acid. For human treatment: rifaximin, erythromycin, 
vancomycin, chloramphenicol and tetracycline are commonly used (Rato et al., 2012). 
Macrolides, mainly erythromycin, are also used to treat bovine mastitis in countries like 
France and the USA (Haenni et al., 2010).  
Several studies have reported a decrease in susceptibility of environmental 
streptococci to compounds from the macrolide–lincosamide–streptogramin (MLS) 
group (Tikofsky et al., 2004), and the emergence and spread of resistance of group B 
streptococcus to macrolides, usually in association with resistance to tetracycline 
(Duarte et al., 2004). To study this spread of MLS resistance in bovine Str. uberis and 
Str. agalactiae previous works explored the genes responsible for the resistance to 
erythromycin and pirlimycin, i.e. the most commonly used macrolide and lincosamide 
antibiotics, as well as for tetracycline (Loch et al., 2005).   
The most common macrolide resistance mechanism in Streptococci is ribosomal 
modification by a methylase, which is encoded by an erm gene (ermA and ermB), 
mostly by ermB (Weisblum et al., 1985; Roberts et al., 2002) The ermB methylase 
confers resistance to erythromycin and inducible or constitutive resistance to 
lincosamines and streptogramin B (Duarte et al., 2004). Resistances to tetracycline are 
often found on the same motile unit as the erythromycin resistance genes and are 
associated to a variety of genes that encode either a protein which pumps tetracycline 
out of the cell or a ribosomal protein which protects the ribosomes from the action of 
tetracycline (Speer et al., 1992). In streptococcal species, the tetracycline resistance 
genes tetM, tetO, tetT, tetW, tetL, tetQ, tetK and tetS have been found (Pires et al., 
2005; Aminov et al., 2001; Ng et al., 2001; Rato et al., 2012). This work, for practical 
reasons and due to lack of time and resources, focused only in the tetS gene, because 
it was associated to phenotypes not related to ermB gene on data obtained by Rato et 
al. (2012).  
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The resistance to lincosamide antibiotics, such as pirlimycin, occurs due to an 
alteration of a specific adenine in the 23S rRNA, and also confers cross-resistance to 
macrolide, lincosamide, and streptogramin B type antibiotics (Lecercq et al., 1991). 
This resistance is related with the linB gene, known to be carried by a plasmid of 
Enterococcus faecium (Bozdogan et al., 1999), emphasizing the implication of 
horizontal gene transfer of antimicrobial resistance genes between bovine mastitis 
pathogens (Rato et al., 2012). 
 
6. Integration of molecular tools into veterinary epidemiology 
Molecular epidemiology is defined as an interdisciplinary approach to the study of the 
distribution, patterns, causes, and effects of infectious or non-infectious disease in 
human and animal populations through the use of molecular biology methods. In this 
context molecular epidemiology encompass disciplines such as epidemiology, 
molecular biology and population genetics (Muellner et al., 2011; Riley, 2004). 
Nowadays, with the advancement of technology, it is increasingly faster and easier to 
generate molecular typing data and to efficiently analyse such data with new and better 
bioinformatics tools.  Moreover, these technologies are becoming more widely 
available, offering new and powerful tools to increase our understanding of the 
epidemiology of important pathogens. A major advantage of molecular tools is the 
capacity to process a large number of strains or a large number of loci in same 
pathogen at the same time, yielding unambiguous data that can easily be stored and 
shared (Muellner et al., 2011; Archie et al., 2009). The integration of these data into 
epidemiological models and investigations could help understanding the key 
epidemiological factors between persistent pathogens and their evolution through time 
and space (Muellner et al., 2011).  
When an outbreak of mastitis occurs, the molecular study and characterization of 
differences between and within species, the presence of adaptive mechanisms to the 
mammary environment and knowing of the transmission mechanisms is determinant 
for the veterinary to develop efficient control strategies and implement measures to 
prevent future outbreaks. This is especially important due to the fact that bovine 
mastitis can either be caused by contagious or environmental pathogens and is 
essential understand the diversity and behavior of Str. uberis and Str. agalactiae in 
herds (Muellner et al., 2011; Rato et al, 2008). 
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Another practical application of molecular tools into veterinary epidemiology is the 
study of antibiotic resistance genes. It is increasingly important to perform a fast and 
accurate detection of emerging antibiotic resistance among the bacterial pathogens. 
However, some of them are fastidious organisms requiring enriched media and 
modified growth conditions for reliable susceptibility testing and clinical laboratories 
may not be able to rely on a single susceptibility testing method to detect all of these 
emerging resistances.  The use of molecular tools provides a new and perhaps more 
definitive approach for detection of antimicrobial resistances through the use of genetic 
probes or nucleic acid amplification techniques for direct detection of genes known to 
encode certain resistance mechanisms, with high sensitivity and specificity (Frye et al., 
2000).  
 
7. Objectives 
The epidemiological and evolutionary studies of Streptococcus agalactiae and 
Streptococcus uberis within the context of bovine mastitis presented in this work were 
carried at the Microbial Diversity and Evolution (MDE) group, CIBIO. Overall, this study 
aimed to: 
i. Characterize important virulence factors and antimicrobials resistances 
described in the literature for Str. agalactiae and Str. uberis within the context of 
bovine mastitis. 
ii. Obtain and store a consistent number of strains to perform epidemiological and 
evolutionary studies.  
iii. Obtain gene-specific DNA markers and determinate their presence in numerous 
isolates of Str. agalactia and Str. uberis obtained from cows in herds near to 
Porto, Portugal.  
iv. Validate the selected markers using PCR-based techniques and dot blot 
hybridisation assays. 
v. Evaluate if there are significant differences among strains, and try to correlate 
these data with the clinical information available (CCS and clinical mastitis). 
vi. Implement the methodological ground to carry out epidemiological and 
molecular evaluations in causative agents of bovine mastitis.   
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MATERIALS AND METHODS 
1. Milk samples and bacterial isolates 
Milk sampling was performed in all lactating cows of 11 dairy herds in an intensive 
system, including in the sampling individuals not showing signs of mastitis and cows 
with clinical mastitis. The four teats were cleaned with a paper towel immersed in an 
antiseptic solution and then, the teat end was disinfected with cotton dampened with 
alcohol (70%). The foremilk was discarded and 20 ml of milk were collected, about 5 ml 
from each quarter. The samples were analyzed by SEGALAB (Laboratório de 
Sanidade Animal e Segurança Alimentar, S.A.) with species identification performed 
using the VITEK 2 system (bioMérieux, Durham, NC). A total of 61 strains of 
Streptococcus agalactiae and 10 strains of Streptococcus uberis were isolated (Table 
I). 
Table I: Streptococcus strains isolated for this study. 
Strain Species Location Herd 
CCS 
(x10
3
) * 
Clinical mastitis 
(Yes/No) * 
Source 
SA35 Streptococcus agalactiae Barcelos A 56 Y SEGALAB 
SA36 Streptococcus agalactiae Barcelos A 662 N SEGALAB 
SA37 Streptococcus agalactiae Barcelos A 1716 N SEGALAB 
SA38 Streptococcus agalactiae Barcelos A 253 N SEGALAB 
SA39 Streptococcus agalactiae Barcelos A 7197 N SEGALAB 
SA40 Streptococcus agalactiae Barcelos A 31 N SEGALAB 
SA41 Streptococcus agalactiae Barcelos A 327 N SEGALAB 
SA42 Streptococcus agalactiae Barcelos A 1067 N SEGALAB 
SA43 Streptococcus agalactiae Barcelos A 91 N SEGALAB 
SA44 Streptococcus agalactiae Barcelos A 186 N SEGALAB 
SA45 Streptococcus agalactiae Barcelos A 1232 N SEGALAB 
SA46 Streptococcus agalactiae Barcelos A 157 N SEGALAB 
SA47 Streptococcus agalactiae Barcelos A 254 N SEGALAB 
SA48 Streptococcus agalactiae Barcelos A 141 N SEGALAB 
SA49 Streptococcus agalactiae Barcelos A 2795 Y SEGALAB 
SA50 Streptococcus agalactiae Barcelos A 1815 N SEGALAB 
SA51 Streptococcus agalactiae Barcelos A 719 Y SEGALAB 
SA52 Streptococcus agalactiae Barcelos A 52 N SEGALAB 
SA55 Streptococcus agalactiae Barcelos A 375 N SEGALAB 
SA56 Streptococcus agalactiae Barcelos A 328 N SEGALAB 
SA57 Streptococcus agalactiae Barcelos A 254 N SEGALAB 
SA58 Streptococcus agalactiae Barcelos A 273 N SEGALAB 
SA59 Streptococcus agalactiae Barcelos A 132 N SEGALAB 
SA60 Streptococcus agalactiae Barcelos A 1862 N SEGALAB 
SA62 Streptococcus agalactiae Barcelos A 17431 N SEGALAB 
SA65 Streptococcus agalactiae Barcelos A 1564 N SEGALAB 
SA66 Streptococcus agalactiae Barcelos A 1150 N SEGALAB 
SA67 Streptococcus agalactiae Barcelos A 15719 Y SEGALAB 
SA68 Streptococcus agalactiae Barcelos A 9153 Y SEGALAB 
SA69 Streptococcus agalactiae Barcelos A 2247 N SEGALAB 
SA74 Streptococcus agalactiae Barcelos A 979 N SEGALAB 
SA76 Streptococcus agalactiae Barcelos B 1784 N SEGALAB 
SA77 Streptococcus agalactiae Barcelos B 251 N SEGALAB 
SA78 Streptococcus agalactiae Barcelos B 1749 N SEGALAB 
SA79 Streptococcus agalactiae Barcelos B 927 N SEGALAB 
SA80 Streptococcus agalactiae Barcelos B 3713 N SEGALAB 
SA82 Streptococcus agalactiae Póvoa Varzim C 334 N SEGALAB 
SA83 Streptococcus agalactiae Póvoa Varzim C 712 N SEGALAB 
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Table 1 (Continued)   
Strain Species Location Herd 
CCS 
(x10
3
) * 
Clinical mastitis 
(Yes/No) * 
Source 
SA84 Streptococcus agalactiae Póvoa Varzim C 1937 N SEGALAB 
SA85 Streptococcus agalactiae Póvoa Varzim C 9215 N SEGALAB 
SA86 Streptococcus agalactiae Póvoa Varzim C 3735 N SEGALAB 
SA87 Streptococcus agalactiae Póvoa Varzim C 213 N SEGALAB 
SA88 Streptococcus agalactiae Póvoa Varzim C 1017 N SEGALAB 
SA89 Streptococcus agalactiae Póvoa Varzim C 909 N SEGALAB 
SA90 Streptococcus agalactiae Barcelos A 5882 N SEGALAB 
SA91 Streptococcus agalactiae Penafiel D 997 N SEGALAB 
SA92 Streptococcus agalactiae Penafiel D 919 N SEGALAB 
SA93 Streptococcus agalactiae Barcelos E 346 N SEGALAB 
SA94 Streptococcus agalactiae Barcelos E 328 N SEGALAB 
SA95 Streptococcus agalactiae Póvoa Varzim F 78 N SEGALAB 
SA96 Streptococcus agalactiae Póvoa Varzim F 4512 N SEGALAB 
SA97 Streptococcus agalactiae Póvoa Varzim F 107 N SEGALAB 
SA98 Streptococcus agalactiae Póvoa Varzim F 2463 N SEGALAB 
SA99 Streptococcus agalactiae Póvoa Varzim F 56 N SEGALAB 
SA100 Streptococcus agalactiae Póvoa Varzim G 381 N SEGALAB 
SA101 Streptococcus agalactiae Póvoa Varzim G 520 N SEGALAB 
SA102 Streptococcus agalactiae Póvoa Varzim G 670 N SEGALAB 
SA103 Streptococcus agalactiae Póvoa Varzim G 6475 N SEGALAB 
SU10 Streptococcus uberis Barcelos J ** Y SEGALAB 
SU11 Streptococcus uberis Amarante H ** Y SEGALAB 
SU13 Streptococcus uberis Amarante H 11744 Y SEGALAB 
SU14 Streptococcus uberis Vila Verde I 2134 N SEGALAB 
SU15 Streptococcus uberis Barcelos J *** Y SEGALAB 
SU16 Streptococcus uberis Barcelos E 541 N SEGALAB 
SU17 Streptococcus uberis Barcelos E 16665 Y SEGALAB 
SU18 Streptococcus uberis Amarante H 311 N SEGALAB 
SU19 Streptococcus uberis Póvoa Varzim K 15650 Y SEGALAB 
SU20 Streptococcus uberis Barcelos J 25522 Y SEGALAB 
SA53* Streptococcus agalactiae Barcelos A 74 N SEGALAB 
SA54* Streptococcus agalactiae Barcelos A 2969 N SEGALAB 
(*) These strains were after confirmed as Staphylococcus pasteuri by sequencing of the 16S rRNA gene 
and withdrawn from the study. 
Seventeen strains characterized in the work of Almeida et al., (2013), were used for 
controls. (Table II).  
Table II: Bacterial strains used for controls (Almeida et al., 2013). 
Strain Species Location Source 
SAA9 Streptococcus agalactiae LMG 15083 - LMG 
SA7 Streptococcus agalactiae Vila do Conde SEGALAB 
SA8 Streptococcus agalactiae Vila do Conde SEGALAB 
SA11 Streptococcus agalactiae Trofa SEGALAB 
SUA12 Streptococcus uberis LMG 9465 - LMG 
SU2 Streptococcus uberis Barcelos SEGALAB 
SU3 Streptococcus uberis Barcelos SEGALAB 
SB A10 Streptococcus bovis LMG 8518 - LMG 
SS4 Streptococcus dysgalactiae - SEGALAB 
SPA11 Streptococcus parauberis LMG 12174 - LMG 
SAUR1 Staphylococcus aureus LMG 8224 - LMG 
SHAA8 Staphylococcus haemolyticus LMG 13349 - LMG 
SPA1 Staphylococcus pasteuri Vila do Conde SEGALAB 
E2 Enterococcus faecium Barcelos SEGALAB 
EFA2 Enterococcus faecalis LMG 7937 - LMG 
LLA6 Lactococcus lactis subsp. lactis LMG 6890 - LMG 
VFA13 Vagococcus fluvialis LMG 12318 - LMG 
LMG - Belgian Co-ordinated collections of microorganisms, Gent, Belgium; 
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2. Culture conditions and DNA extraction 
All strains were cultured in Brain Heart Infusion (BHI) (biolab®, Hungary) medium at 
37°C. Bacterial DNA was extracted using the EaZy Nucleic Acid bacterial DNA 
purification KIT (Omega Bio-Tek, Norcross, GA), according to the manufacturer’s 
instructions.  Quantification of DNA samples was done using the Qubit 2.0 Fluorometer 
HS Assay (Invitrogen, Carlsbad, CA) and quality was assessed by electrophoresis in 
1% agarose gels.  
 
3. PCR amplification 
The oligonucleotide primers for the detection of the ermB, linB, tetS, sua and fbsB 
genes (Table III) were designed using with Primer3 software (http://frodo.wi.mit.edu/) 
and synthesized by STABVida (Lisbon, Portugal). Amplicon specificity was assessed 
using BLAST (Basic Local Alignment Search Tool) (Altschul 1990) (BLAST, 
http://blast.ncbi.nlm.nih.gov/). 
Table III:  NCBI Reference Sequence or GeneBank accession number used to design primers. 
Gene Designed in 
NCBI / GeneBank 
accession no. 
ermB 
Streptococcus uberis strain 330 ermB gene, 
partial cds 
EF422362.1 
tetS 
Streptococcus uberis TetS (tetS) gene, partial 
cds 
EF092839.1 
linB 
Streptococcus uberis isolate QMP Z3-369 
lincosamide nucleotidyltransferase (linB) gene, 
partial cds 
EF539833.1 
sua 
Streptococcus uberis 0140J chromosome, 
complete genome 
NC_012004.1 
fbsB 
Streptococcus agalactiae NEM316, complete 
genome 
NC_004368.1 
 
The PCR master mix contained: 25ng of bacterial DNA, 0,2 μM of each primer, 1x 
DreamTaq buffer, containing 1.5 mM of MgCl2 (Fermentas, Ontario, Canada), 1 U of 
DreamTaq DNA polymerase (Fermentas), 0.2 mM of each dNTPs (Fermentas). The 
reaction was performed with an initial denaturation of 95°C for 5 min, followed by 35 
cycles at 95° for 30s, 55°C for 30s and 72°C for 45s with a final extension of 10 min at 
72°C. PCR products were visualized on 1.5% agarose gels stained with GelRed 
(Biotum) at 80V. PCR amplicons were purified from agarose gels using the GFX PCR 
DNA and gel band purification kit (GE Healthcare, Buckinghamshire, United Kingdom) 
and the identity of these amplicons was confirmed by sequencing (STAB Vida, 
Portugal). 
16 
 
Table IV: Taxa-specific markers with PCR primer sequence used in this study. 
Marker Primer Sequence (5´-3’) Ta 
Amplicon 
length 
Specificity References 
F1 
TTATGCTCGTCTTGCTCTTTACGG 
GCACACGTCCAAGTGATGTAGCTG 
54.6°C 285bp Streptococcaceae 
Almeida et 
al., 2013 
A1 
ATGTAGCTGCTGATTCTGTCATAA 
AATAGCTGGTGTAGATTTGACTGC 
52.6°C 314bp Str. agalactiae 
Almeida et 
al., 2013 
SU 
TCGTTTGTATACGCTTGATGCT 
CACGTCTCTATAAAAGGAATTCCC 
50.6°C 229bp Str. uberis 
Almeida et 
al., 2013 
 
Table V: Functional markers with PCR primer sequence used in this study. 
Marker 
Target 
gene 
Primer Sequence (5´-3’) Ta Amplicon length References 
sua sua 
TCAGTTGTTGTGATTGCTGACGTC 
CAAACAAGTGGTTTCAGGTCCATT 
56°C 600bp This study 
fbsB fbsB 
ACAAAGTTCAGTTGCGCAAACT 
CGCGATGAGATTGATTTACTCA 
52.9°C 525bp This study 
ermB ermB 
AAAGCCATGCGTCTGACATC 
TGTGGTATGGCGGGTAAGTT 
52.5°C 194bp This study 
linB linB 
CCTGATACGAAGGCTATGCTT 
GGTGACTTTGCAAATCCATAACT 
50.0°C 403bp This study 
tetS tetS 
AGGACAAACTTTCTGACGACA 
CTGAATTGAGTTGTGTGGGTGA 
49.1°C 306bp This study 
FO1 fruR 
CGACATCAAAAAAACAACTAACAC 
TCCACCACGTTATTGAGAGTTT 
50.6°C 331bp 
Richards et al., 
2011 
FO3 fruD 
TCTCAATTTCTTCGATCTCATGTGC 
CAGGTCTTGTTGTCGAAAACGATTA 
52.6°C 348bp 
Richards et al., 
2011 
NU1 nsuR 
CCAAGGTTGCAGCGCATTT 
CCCCTTATTGTCTTGATGGGATT 
51.5°C 331bp 
Richards et al., 
2011 
NU3 nsuf 
AATCAAATCGTTGATGAAAATGACC 
AAACTTCTCCGTAATCCCAAACTTC 
50.6°C 502bp 
Richards et al., 
2011 
V1 hasC 
TGCTTGGTGACGATTTGATG 
GTCCAATGATAGCAAGGTACAC 
58.0°C 300bp 
Ward et al., 
2001 
V2 gapC 
GCTCCTGGTGGAGATGATGT 
GTCACCAGTGTAAGCGTGGA 
55.0°C 189bp 
Reinoso. et al. 
2011 
V3 oppF 
GGCCTAACCAAAACGAAACA 
GGCTCTGGAATTGCTGAAAG 
54.0°C 419bp 
Smith et al., 
2002 
 
4. Dot Blot screening 
DNA probes were obtained from purified PCR amplicons (≈ 150 ng), using the using 
the DIG-High Prime labelling kit (Roche, Basel, Switzerland) according to 
manufacturer’s instructions. 
For Dot Blot hybridisation assays, 100ng of heat-denatured DNA from each bacteria 
was spotted into a nylon membrane using a Bio-Dot apparatus (Bio-Rad) (Table VI, 
Figure 1). Hybridisation was carried out overnight at 68°C with a probe concentration of 
100ng/ml. Washing and detection were carried out according to the DIG system 
instructions (Roche). DIG-labelled nucleic acids were detected by chemiluminescence 
using a Molecular Imager Chemi-Doc system (Bio-Rad). 
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. Table VI: Layout of the membranes used in the dot blot hybridisation assays 
 1 2 3 4 5 6 7 8 9 10 11 12 
A C+ SA35 SA36 SA37 SA38 SA39 SA40 SA41 SA42 SA43 SA44 C+ 
B C- SA45 SA46 SA47 SA48 SA49 SA50 SA51 SA52 SA55 SA56 C- 
C SA57 SA58 SA59 SA60 SA62 SA65 SA66 SA67 SA68 SA69 SA74 SA76 
D SA77 SA78 SA79 SA80 SA90 SA93 SA94 SA81 SA82 SA83 SA84 SA85 
E SA86 SA87 SA88 SA89 SA95 SA96 SA97 SA98 SA99 SA100 SA101 SA102 
F SA103 SA91 SA92 - SU10 SU15 SU16 SU17 SU20 SU19 SU11 SU13 
G C- SU18 SU14 - SAA9 SA7 SA8 SA11 SUA12 SU2 SU3 C- 
H C+ SBA10 SS4 SPA11 SAUR1 SHAA8 SPA1 E2 EFA2 LLA6 VFA13 C+ 
.NOTE: SA53 and SA54 were withdrawn in this final dot blot membrane 
 
The Dot Blot hybridisation analysis was performed using an image-processing 
algorithm (MATLAB-based algorithm), that calculates the probability of each dot being 
a positive result, using as references the positive and negative controls present in each 
membrane. The exposure time of the Chemidoc system was adjusted so that all dots 
were below pixel saturation (Marcal et al., 2009; Albuquerque et al., 2011) 
 
 1 2 3 4 5 6 7 8 9 10 11 12    
A + a a a a a a a a a a +  + Positive control 
B - a a a a a a a a a a -  - Negative control 
C a a a a a a a a a a a a  a Str. agalactiae 
D a a a a a a a a a a a a  u Str. uberis 
E a a a a a a a a a a a a  a1 Str. agalactiae LMG 
F a a a - u u u u u u u u  a2 Str. agalactiae used as controls 
G - u u - a
1
 a
2
 a
2
 a
2
 u
1
 u
1
 u
1
 -  u
1 
Str. uberis used as controls 
H + o o o o o o o o o o +  o Other species used as controls 
Figure 1: Layout of the membranes used in the dot blot hybridisation assays. 
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RESULTS 
1. Frequency in herds  
The implementation of milk quality protocols is usual in dairy herds, establishing control 
measures to reduce the number of clinical mastitis and to decrease the CCS in milk. In 
this context, veterinarians perform one or two visits per year in order to collect samples 
from all lactating cows. This measure allows to detect cows and teats infected with 
pathogenic agents causing clinical and sub-clinical infections.  
The results obtained from 5 of these visits, performed by SEBALAB veterinarians, are 
represented in Table VII. In which the frequency of Str. agalactiae and Str. uberis in 
some of the studied herds can be observed.  
Table VII: Number of Str. agalactia (SA) and Str. uberis (SU) found in consecutive visits in which all the 
lactating cows were tested. 
Visit 
Herd A Herd E Herd F Herd H 
Year n SA SU Year n SA SU Year n SA SU Year n SA SU 
1 2010 149 29 0 2010 83 35 2 2010 62 26 0 2010 98 0 8 
2 2011 175 26 3 2011 79 14 4 2011 65 12 3 2010 66 0 4 
3 2011 181 24 0 2013 91 9 4 2012 71 28 0 2011 106 0 11 
4 2012 195 9 0 - - - - 2013 53 14 0 2012 126 0 2 
5 2012 173 46 0 - - - - - - - - - - - - 
NOTE: These data only comprises the lactating cows at the moment of visit. 
2. Preliminary identification of isolates 
A preliminary test was carried out using taxonomic markers specific for Streptotoccus 
(F1), Str. agalactiae (A1) and Str. uberis (SU) to confirm the identity of the 61 isolates 
of Str. agalactiae and 10 isolates of Str. uberis obtained from cows. The obtained 
results showed that hybridisation with these taxonomic markers was not observed in 2 
strains: SA53 and SA54 (Fig.1-Appendix). These isolates, identified as Staphylococcus 
pasteuri by sequencing of the 16S rRNA gene, were withdrawn from the study. 
 
3. Taxonomic markers 
Regarding marker F1, dot blot hybridisation showed a specificity of 100% for all 79 
species belonging to the Streptococcus genus, including Str. agalactia, Str. uberis and 
the control strains Str. dysgalactiae, Str. bovis and Str. parauberis.  Marker A1 was 
specific for all 63 (100%) Str. agalactiae strains. Finally, marker SU presented positive 
hybridisation in all 13 Str. uberis and negative signal for all the other species, with the 
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exception of 1 Str. agalaciae strain, which showed a very small hybridisation (average 
probability of 0.26; Table I-Appendix) with this marker. The hybridisation results 
obtained  for taxonomic markers are represented in Table VIII, and Figure 2-Appendix. 
Table VIII: Results obtained from the dot blot assays for taxa-specific markers (F1, A1 and SU).  
Species 
 Taxa-specific markers 
n F1 A1 SU 
Str. agalactiae 59 59 (100%) 59 (100%) 1 (1.7%)* 
Str. uberis 10 10 (100%) - 10 (100%) 
Str. agalactiae LMG
(A)
 1 1 (100%) 1 (100%) - 
Str. agalactiae 
(B)
 3 1 (100%) 3 (100%) - 
Str. uberis
(C)
 3 1 (100%) - 3 (100%) 
Str. bovis 1 1 (100%) - - 
Str. dysgalactiae 1 1 (100%) - - 
Str. parauberis 1 1 (100%) - - 
S. aureus 1 - - - 
S. haemolyticus 1 - - - 
S. pasteuri 1 - - - 
E. feacium 1 - - - 
E. faecalis 1 - - - 
L. lactis 1 - - - 
Vagococcus fluvialis 1 - - - 
(A) Str. agalactiae LMG from human origin; (B) Str. agalactiae used as positive controls; (C) Str. uberis 
used as positive  controls; (*) It was observed a small hybridisation.  
 
4. Virulence factors  
4.1. Research and selection of virulence factors  
Several putative virulence factors have been identified in Str. agalactiae and Str. 
uberis. A survey of the literature allowed to select virulence factors that may have an 
important role, or at least provide some competitive advantage, during infection of the 
mammary gland (Table IX and X). Since it was not possible to test all of these virulence 
factors in this study, only the regions related to adhesion and invasion, 
antiphagocytosis, ability to grown in milk and production of bacteriocin were selected 
for further analysis.  
Regarding adhesion and invasion to epithelium, the fibrinogen binding protein (FbsB) 
for Str. agalactiae and the adhesion molecule (Suam) for Str. uberis were considered 
for this study. The hyaluronic acid capsule (V1) was tested due to its antiphagocytosis 
properties. Concerning the ability of Str.agalactiae to grow in milk and survive in 
environment, the fructose operon (FO1 and FO3), Glyceraldehyde-3-phosphate (V2) 
and oligopetide transport system (V3) were selected. Finally, for study of bacteriocin 
production the nisin U region (NU1 and NU3) was chosen. 
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Table IX: Virulence factors for Str. agalactiae, identified in the literature. 
Str. agalactiae 
 
  
Function and name Gene Source 
 Adhesion   
  Fibrinogen binding protein fbsB Jacobsson et al, 2003; Gutekunst et al, 
2004   Laminin-binding protein lmb Chen et al, 2005 
  Fibrinnectin-binding protein pavA Chen et al, 2005 
 Invasion   
  α-C protein bca  
  Fibrinogen binding protein fbsB Gutekunst et al, 2004 
 Antiphagocytosis   
  β-C protein cba Chen et al, 2005 
  Capsule * Chen et al, 2005 
 Ability to grown in milk/environment   
  Fructose operon fruC, fruD, fruP, fruR Richards et al, 2011 
  Lactose operon  Richards et al, 2011 
  Glyceraldehyde-3-phosphate 
dehydrogenase 
gapC Reinoso et al, 2011 
  Oligopetide transport system opp Smith et al, 2002 
 Complement protease   
  C5a peptidase scpB Chen et al, 2005 
 Toxin   
  CAMP factor cfb Chen et al, 2005 
 Bacteriocins   
  Nisin U nsu Richards et al, 2011; Wirawan et al, 2006 
(*) Several gens were identified and are listed in Chen et al., 2005. 
Table X: Virulence factors for Str. uberis, identified in the literature. 
Str. uberis   
Function and name Gene Source 
 Adhesion and Invasion   
  Str. uberis adhesion molecule sua Almeida et al, 2006 
  Lactoferrinbinding proteins 
proteins 
lbp Moshynskyy et al, 2003 
 Antiphagocytosis   
  Hyaluronic acid  capsule hasA, hasB, hasC Ward et al, 2001 
 Ability to grown in milk/environment   
  Plasminogen activator pauA/ pauB, skc Rosey et al, 1999 ; Ward & Leigh, 2002; 
Johnsen et al., 1999 
  Fructose operon fruC, fruD, fruP, fruR Richards et al, 2011 
  Lactose operon  Richards et al, 2011 
  Glyceraldehyde-3-phosphate 
dehydrogenase 
gapC Reinoso et al, 2011 
  Oligopetide transport system opp Smith et al, 2002 
 Toxin   
  CAMP factor cfu Reinoso et al, 2011 
 Bacteriocin   
  Nisin U nsu Wirawan et al, 2006 
  Uberolysin ublA Wirawan et al, 2007 
 
4.2. Virulence markers 
Results obtained with markers from the fructose operon (FO1 and FO3) revealed that 
these genes were present in all 62 (100%) Str. agalactiae from bovine origin. However, 
the control strains S. agalactiae LMG 15083 of Human origin presented a lower signal 
for this operon. The fructose operon was also found in Str. dysgalactiae and Str. 
parauberis. The fbsB gene was specific for all 63 (100%) Str. agalactiae. The nisin U 
operon markers (NU1 and NU3) were present in 5 (38%) strains of Str. uberis (3 in the 
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studied strains and 2 in control strains). The remaining 8 (62%) strains of Str. uberis 
presented a small hybridisation for NU3 and none for NU1. The nisin U operon was 
also found in 2 (3.2%) Str. agalactiae from control strains. The hyaluronic acid capsule 
(V1) and Str. uberis adhesion molecule (sua) were specific for all 13 (100%) Str. uberis. 
The gapC marker (V2) was present in all 13 (100%) Str. uberis tested. Regarding Str 
agalactiae, the V2 marker provided positive signals for 54 (85.7%) strains, 50 in the 
studied ones and 4 in the control strains. A lower signal for V2 was observed in 6 
(9.5%) and no hybridisation for the remaining 3 (4.8%) strains of Str agalactiae. In 
control strains, gapC gene was present in the environmental streptococci Str. 
parauberis. Dot blots using the oppF gene marker (V3) were specific for all 13 (100%) 
Str. uberis strains tested, in addition to Str. parauberis.  
The strains were aggregated in virulence genotypes (VG), according to the results of 
the dot blot assays for virulence markers, with the respective average CCS and 
number of clinical mastitis reported for each genotype. In this work, 10 different VG for 
the studied strains were observed: 3 VG for Str. agalactiae and 7 VG for Str. uberis. 
The most frequent virulence genotype in Str agalactiae was VG1, positive for: FO1, 
FO3, V2 and fbsB. VG1 was present in 50 (84.8%) strains, with an average CCS of 
2043±3167 x103 cells/ml and 4 of these 50 strains (8%) were isolated from clinical 
mastitis. With a similar pattern to VG1 but with a lower hybridisation for the gapC gene, 
VG2 was observed in 6 of 59 strains (10.2%) with an average CCS of 
3062±6233cells/ml and 1 (16.7%) strain isolated from clinical mastitis. Finally, VG3 
differs from the other two by presenting negative hybridisation for the gapC gene. This 
genotype appears with less frequency, only present in 3 (5%) strains with an average 
CCS of 370±330cells/ml. None of the VG3 strains were isolated from clinical mastitis 
(Table XI).  
Str. uberis showed a larger genetic variety, with 7 different virulence genotypes in only 
10 strains. The hyaluronic acid capsule (V1), Glyceraldehyde-3-phosphate (V2), 
oligopetide transport system (V3) and the ability to adhere and invade epithelium 
conferred by gene sua are common to all genotypes. On the other hand, the fructose 
operon and nisin U operon vary between genotypes (Table XI).  
In control strains 10 more different VG for all species were found. Particular relevance 
should be given to VG11, in which the nisin U operon in Str. agalactiae was found 
(Table XII).  
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Table XI: Number of strains observed for each virulence genotype pattern (VG) obtained from the dot blot 
assays for virulence and functional markers (FO1, FO3, NU1, NU3, V1, V2, V3, fbsB and sua) with the 
average CCS and number of stains isolated from clinical mastitis, in the studied strains. Green (+): Positive 
hybridisation, average probability above 0.75; Yellow (i): Intermediate hybridisation, average probability 
between 0.25 and 0.75; Red (-): Negative hybridisation, average probability below 0.25. 
Virulence 
Genotype  
Result for markers 
Str. 
agalactiae 
(n= 59) 
Str. 
uberis 
(n=10) 
Average 
CCS (x10
3
) 
for VG 
Strains 
isolated from 
clinical 
mastitis   
F
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1
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3
 
N
U
1
 
N
U
3
 
V
1
 
V
2
 
V
3
 
fb
s
B
 
S
u
a
 
VG1 + + - - - + - + - 50(85%) - 2043±3167 4(8%) 
VG2 + + - - - i - + - 6(10%) - 3062±6233 1(16.7%) 
VG3 + + - - - - - + - 3(5%) - 370±330 0(0%) 
VG4 i i + + + + + - + - 1(10%) 25522 1(100%) 
VG5 i i - i + + + - + - 2(20%) 16152±717 2(100%) 
VG6 i - - i + + + - + - 1(10%) 541 0(0%) 
VG7 - i + + + + + - + - 1(10%) 311 0(0%) 
VG8 - i - i + + + - + - 1(10%) 11744 1(100%) 
VG9 - - + + + + + - + - 1(10%) * 1(100%) 
VG10 - - - i + + + - + - 3(30%) 2134 ** 2(66.7%) 
(*) The CCS was not performed due to insufficient amount of milk. (**) In 2 of 3 samples, milk was 
considered improper for consumption and the CCS was not performed. 
 
Table XII: Results observed for each virulence genotype pattern (VG) obtained from the dot blot assays 
for functional and virulence markers (FO1, FO3, NU1, NU3, V1, V2, V3, fbsB and sua) in the control 
strains. Green (+): Positive hybridisation, average probability above 0.75; Yellow (i): Intermediate 
hybridisation, average probability between 0.25 and 0.75; Red (-): Negative hybridisation, average 
probability below 0.25. 
Virulence 
genotypes 
Result for markers 
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VG1 + + - - - + - + - - 1 - - - - - - - - - - - 
VG9 - - + + + + + - + - - 1 - - - - - - - - - - 
VG11 + + + + - + - + - - 2 - - - - - - - - - - - 
VG12 i i - - - + - + - 1 - - - - - - - - - - - - 
VG13 + + - - - - - - - - - - - 1 - - - - - - - - 
VG14 + + - - - + + - - - - - - - 1 - - - - - - - 
VG15 - - - - - - i - - - - - 1 - - - - - - - - - 
VG16 i i - + + + + - + - - 1 - - - - - - - - - - 
VG17 - - + + + + + - + - - 1 - - - - - - - - - - 
VG18 - - - - - - - - - - - - - - - 1 1 1 1 1 1 1 
   Number of strains: 1 3 3 1 1 1 1 1 1 1 1 1 1 
(A) Str. agalactiae LMG from human origin; (B) Str. agalactiae used as positive controls; (C) Str. uberis 
used as positive  controls 
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Regarding the relation between virulence genotypes and herds, it was observed that 
VG1 was present in 6 (86%) of the 7 herds infected with Str. agalactiae (herd E was 
the only exception). Whereas VG2 was present in 4 (57%) herds and VG3 in only 3 
(42%) herds. Within the same herd VG1 strains, if present, were always in greater 
number than VG2 and VG3 strains. A great diversity of different virulence patterns was 
present in Str. uberis strains, with different VG found in the same herd. On the other 
hand, strains with identical VG were also found in different herds (table XIII). 
Table XIII: Distribution of virulence genotypes from Str. agalactiae (VG1, VG2 and VG3) and Str. uberis 
(VG4 to VG10) in the studied herds (A to J). 
Virulence 
genotype 
Number 
of 
strains 
Herd  
A B C D E F G H I J K 
n=32 n=5 n=9 n=2 n=4 n=5 n=4 n=3 n=1 n=3 n=1 
Str. agalactiae 59 32 5 9 2 2 5 4 0 0 0 0 
VG1 50 28 4 8 2 - 5 3 - - - - 
VG2 6 3 1 - - 1 - 1 - - - - 
VG3 3 1 - 1 - 1 - - - - - - 
             
Str. uberis 10 0 0 0 0 2 0 0 3 1 2 1 
VG4 1 - - - - - - - - - 1 - 
VG5 2 - - - - 1 - - - - - 1 
VG6 1 - - - - 1 - - - - - - 
VG7 1 - - - - - - - 1 - - - 
VG8 1 - - - - - - - 1 - - - 
VG9 1 - - - - - - - - - 1 - 
VG10 3 - - - - - - - 1 1 1 - 
  
The complete data obtained for virulence markers, with the average probability for each 
marker in all strains, can be consulted in Table I-Appendix and Figure 3-Appendix. 
 
5. Antimicrobials markers  
The erythromycin resistance gene ermB, the tetracycline resistance gene tetS and the 
pirlimycin resistance gene linB were screened by PCR in some strains from each herd. 
Positive amplification was possible for the ermB gene and after amplicon identity 
confirmation by sequencing, it was possible to obtain a probe for dot blot analysis. 
However, it was not possible to obtain an amplicon with the intended size for the genes 
linB and tetS in none of the tested strains. 
Considering the studied strains, the dot blot assays with the ermB marker (Figure 4-
Appendix) revealed positive results for all 10(100%) Str. uberis. In Str. agalactia a 
positive hybridisation was observed in 5 (8.5%) strains and a lower signal in 2 (3.4%) 
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other. These 7 strains were isolated from herd C, where 7 out of 9 (77.8%) isolates 
presented the resistance gene for erythromicyne. All the remaining 52 Str. agalactiae 
strains showed negative signal with this marker. In the control strains, all Str. uberis 
and 2 (50%) Str. agalactiae presented a positive signal with no signal observed in the 
remaining strains (Table XIV).  
Table XIV: Number of strains observed for each in the dot blot assays for antimicrobial markers (ermB) in 
the studied strains.  
Species 
 ermB marker 
n Positive hybridisation 
Intermediate 
hybridisation 
Str. agalactiae 59 5 (8.5%) 2 (3.4%) 
Str. uberis 10 10 (100%) - 
Str. agalactiae LMG
(A)
 1 - - 
Str. agalactiae 
(B)
 3 2 (66.7%) - 
Str. uberis
(C)
 3 2 (66.7%) 1 (33.3%) 
Str. bovis 1 - - 
Str. dysgalactiae 1 - - 
Str. parauberis 1 - - 
S. aureus 1 - - 
S. haemolyticus 1 - - 
S. pasteuri 1 - - 
E. feacium 1 - - 
E. faecalis 1 - - 
L. lactis 1 - - 
Vagococcus fluvialis 1 - - 
(A) Str. agalactiae LMG from human origin; (B) Str. agalactiae strains used as positive controls; (C) Str. 
uberis strains used as positive  controls; 
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DISCUSSION  
1. Frequency in mastitis 
Despite the several control measures implemented in herds for the prevention and 
treatment of mammary infections, the frequency of clinical and sub-clinical mastitis 
remains high. Among the etiological agents causing mastitis, Str. agalactiae and Str. 
uberis are important causes of infection in Portuguese herds. By analysing the 
frequency of isolation of these agents in some herds studied it can be observed that 
they are often isolated from lactating cows (Table VII). Therefore, it is important to 
conduct molecular epidemiological studies in order to understand if the new outbreaks 
of Str. agalactia and Str. uberis are related to some virulence factors, cow’s genetics, 
failures in control measures or a combination of all these factors. 
The data of prevalence rates in mastitis as well as the biological characteristics of Str. 
uberis and Str. agalactia isolated from dairy herds in the Portuguese northwest region 
is still scarce. In this work, the genotypic properties of several strains isolated from 
cows of dairy farms from the regions near Porto (Portugal) was investigated, in an 
attempt to define the pathogenic mechanisms and the presence of antimicrobials 
genes in these species. The identification of these putative virulence factors could 
provide relevant data about the evolution, the strategies for evasion of the host 
defences and determinants that allow pathogens to persist throughout time in herds. 
This work also intended to contribute for the development of non-antibiotic disease 
control approaches, of particular importance in dairy herds since the control of mastitis 
is mainly based on the use of antibiotics. 
 
2. Taxonomic genetic markers as detection methods  
The taxa-specific markers F1, SA1 and SU correctly identified all Streptococcaceae, 
Str. agalactiae and Str. uberis, respectively. Despite strain SA86 presenting a small 
hybridisation signal for marker SU, the calculated average probability was only 0.26 
(Table I-Appendix), corresponding to the lower limit of what is considered an 
intermediate hybridisation Also one cannot exclude the possibility that this may be due 
to a technical error when processing the samples in the dot blot assay or due to an 
artefact in the analysis performed by the image-processing algorithm. The results of 
this work reinforce the hypothesis from a previous study (Almeida et al., 2013) 
concerning the good consistency and stability of these markers to be used for 
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identification of the Streptococcus genus, Str. agalactiae and Str. uberis, because they 
show high specificity and sensitivity (Table XV).  
Table XV: Specificity and sensitivity of markers F1, A1 and SU for characterization of the Streptococcus 
genus, Str. agalactiae and Str. uberis.  
 Markers 
 
F1  
(Streptococcus) 
 A1  
(Str. agalactiae) 
 SU  
(Str. uberis) 
 
Positive 
strains 
Negative 
strains 
 Positive 
strains 
Negative 
strains 
 Positive 
strains 
Negative 
strains 
 n=79 n=7  n=63 n=23  n=13 n=72 
Positive 
identification 
79(100%) 0 
 
63(100%) 0 
 
13 (100%) 1(1.4%)* 
Negative 
Identification  
0 7 (100%) 
 
0 23(100%) 
 
0 71(98.6%) 
(*) It was observed a small hybridisation. 
 
3. Virulence genotypes 
Functional traits responsible for pathogenicity are usually located in unstable or 
dynamic genomic regions, which are less reliable for detection purposes. Nevertheless, 
they may provide additional information of the virulence potential of pathogenic 
species. In this study several virulence genotypes (VG) were identified, according to 
the results obtained for the presence of specific virulence-associated genes. 
The results showed that all strains isolated from bovine mammary gland, have the 
genes responsible for adherence and hypothetical invasion of epithelial cells, the gene 
sua in Str. uberis and the gene fbsB in Str. agalactiae. These results differ from other 
studies, in which sua was not present in 20% of the Str. uberis strains isolated from 
udders of cows with mastitis (Reinoso et al, 2011), suggesting that strains with this 
gene have a greater probability of causing mastitis, but is not an obligatory factor to 
establish infection. 
The genes fruD and fruR, involved in fructose utilization, were present in all Str. 
agalactiae strains obtained from bovine samples. The ability to use fructose it is also 
present in other environmental pathogens closely related to Str. agalactiae (including 
Str. dysgalactiae and Str. parauberis). Interestingly, no hybridisation was observed with 
these markers in none of the studied Str uberis, suggesting a different pathway for 
carbon sources in this species that has the capacity to hydrolyse a wide range of 
sugars (Ward et al, 2009).  
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It should be noted that the human strain SAA9 showed a significantly lower 
hybridisation for the fructose operon. Richards et al. (2011), found the complete 
fructose operon in 95% of the bovine samples, but they also did not detected the 
operon in any of the human strains. This data suggests a unique fructose utilization 
pathway for the bovine population of Str. agalactiae, which might facilitate survival in 
the extramammary environment. The fructose operon was present in all virulence 
genotypes found for Str. agalactiae strains tested in this study, supporting the 
hypothesis that, although it may not confer an advantage during infection, strains using 
the fructose pathway survives longer outside the mammary gland, obtaining an 
important adaptive advantage during spread.  
Another factor included in this study was the nisin U operon that may provide a 
competitive advantage during infection (Pryor et al, 2009). The complete nisin U 
operon was found in 3 (30%) strains of Str. uberis isolated for this work, belonging to 
VG4, VG7 and VG8. Interestingly, all of them were isolated from clinical mastitis and 
presented very high CCS. This operon was not observed in the Str. agalactiae 
collected in this work. Nonetheless, it was detected in 2 Str. agalactiae from control 
strains, both from the same herd (Almeida et al, 2013). Despite epidemiological 
information of these 2 strains are not available, this data confirms the exchange of 
genetic material between separate mastitis pathogens species. That might have 
contributed to the continued adaptation of Str. agalactiae to the bovine environment 
through the incorporation of potential virulence factors or antibiotic resistance in the 
genome (Richards et al, 2011).  
The only difference observed in the virulence genotypes of Str agalactiae, was the 
presence (or absence) of the gene gapC. Most of the isolated Str. agalactiae strains 
carry the gene gapC, which has been described as being associated with virulence 
(Ling et al., 2004; Maeda et al., 2004).This virulence is due to the ability to bind several 
host proteins and to resist against reactive oxygen produced by phagocyts (Holzmuller 
et al, 2006). Moreover, it is involved in bacterial energy production and it has 
imunomodulatory properties (Madureira et al, 2007). Comparing the average somatic 
cell and the number of clinical mastitis, it can be observed that there is a difference in 
the severity of infection between the strains with and without the gene. The average 
CCS in infections caused by VG1 strains (with gapC gene) and VG2 strains (with 
possibility to have complete or parcial gapC gene) is substantially higher than the 
observed in the VG3 strains (absence of gapC gene).  Furthermore, 8% of VG1 and 
16.7% of the VG2 were isolated from clinical mastitis, whereas none of the VG3 strains 
were isolated from symptomatic infections. Interestingly, the most severe infections 
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were caused by VG2 strains, which showed an intermediate hybridisation for gapC 
gene, with an average CCS of 3062±6233cells/ml and 16.7% from clinical mastitis. 
This might be due to the reduced number of strains of this genotype, which does not 
allow a very representative statistical data analysis. On the other hand, it is possible 
that some kind of mutation in the gene confers these strains a greater virulence 
potential. Nonetheless, these results support the hypothesis that its presence confers 
an advantage during infection and might increase its severity. VG3 strains found in this 
work showed less serious infections. Nevertheless, due to the reduced number  of 
strains and based to the fact that clinical information is restricted to the time of 
sampling, not taking into account the evolution of the infection throughout time, we 
cannot set aside the possibility of VG3 strains also being able to cause more serious 
infections.  
Regarding Str. uberis, some studies showed prevalence of the gapC gene in 80% of 
the isolates (Reinoso et al, 2011).In this work the gene was present in all studied 
strains, so it is not possible to compare the severity of infection in strains with and 
without the gene. 
Taking into account this increase in the severity of infection, combined with the high 
prevalence of the gene in bovine population of Str. agalactia and Str. uberis, some 
authors have suggested that a GapC protein may be a good target for vaccine 
development (Perez-Casal et al, 2004).  
Strains with hyaluronic acid capsule around them seem to be resistant to phagocytosis 
by bovine neutrophils and establish infection more effectively (Ward et al, 2001; Leight, 
et al, 1991). Nonetheless, some authors argue that hyaluronic acid capsule of Str. 
uberis plays only a minor role in the early stages of infection and is not required for the 
development of infection and clinical mastitis. (Field et al, 2003; Ward et al, 2009). The 
hyaloronic acid capsule production is dependent on the has operon (hasA, hasB and 
hasC). Despite some authors mention that the role of hasC is unclear to capsule 
biosynthesis, it is found with high frequency in capsular phenotypes (Reinoso et al, 
2011). In this work the gene hasC is present in all VGs of Str. uberis, confirming the 
high prevalence of capsulated strains of Str. uberis causing mastitis.  
Finally, the oppF gene, which plays an important role during growth in milk (Smith et al, 
2002), was found in all Str. uberis strains. Comparatively, Reinoso et al. (2011), found 
the oppF gene only in 64.1% of the strains. Once again, due to the absence of strains 
without the gene, we cannot compare the severity patterns of strains with or without 
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thise gene. It is however possible to assume that, based on our study, the prevalence 
of the oppF gene in the dairy herds analysed is higher than in other locations. 
In conclusion, several virulence genotypes were observed associated with mammary 
infections. These genotypes were found within the same herd and among different 
herds, showing that different virulence patterns were able to cause infection. The 
genetic variability is higher in Str. uberis, in which the different virulence patterns are 
able to cause clinical mastitis and apparently none of the virulence genotypes seems to 
be dominant relative to the others. It is important to consider that Str. uberis infections 
may also be dependent on cow’s factors (Reinoso et al, 2011). On the contrary, Str. 
agalactiae presents less genetic variability, with an apparent advantage in the 
frequency and severity of infection for strains containing the gene gapC.  
4. Antimicrobials resistance  
In order to study the emergence and spread of MLS and tetracycline resistance in 
bovine Str.agalactiae and Str. uberi strains the following genes were tested: macrolide 
resistance gene ermB; lincomicine resistance gene linB and tetracycline resistance 
gene tetS. linB and tetS were not detected by PCR in any of the tested strains. 
Moreover, the in vitro disk diffusion method with tetracycline and pirlimycin, using the 
interpretative standards available for these organisms in the European Society of 
Clinical Microbiology and Infection Diseases (EUCAST, http://mic.eucast.org/) also 
showed that the strains tested were susceptible for these compounds.  
In this study, erythromycin resistance mediated by the ermB gene was shown to be 
widespread in Str. uberis, with the 13 (100%) tested strains presenting the gene. This 
confirms the emergence and spread of the macrolide resistance in the environmental 
streptococci.  
Importantly, the ermB gene was found in 7 (11.1%) Str. agalactiae strains. This 
suggests the exchange of genetic material between Str. agalactiae and environmental 
bacteria. Str. agalactiae infections are currently treated effectively with penicillin and 
other compounds, however, there are other mastitis-causing pathogens, or 
environment bacteria, that are less susceptible to antibiotics used against Str. 
agalactiae. This is a cause for concern since that lateral transfer of genes between Str. 
agalactia and other pathogens is frequent and plays a significant role in its evolution 
(Richards et al., 2011). Furthermore, this may result in the acquisition of increased 
antibiotic resistances, penicillin for instance, which would greatly difficult the treatment 
of infections.  
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5. Future Perspectives 
Data from this study should be interpreted with caution because this work has 
evaluated a small number of strains, within a restricted number of herds and to the 
timeframe of the study. Nevertheless, the results obtained in this work provide a 
methodological ground to carry out epidemiological and molecular evaluations of the 
causative agents of bovine mastitis, which may contribute to an efficient control, 
treatment and prevention of bovine mastitis. In the future, it will be important to:  
1) Increase the number of tested isolates in order to obtain a more robust number 
of strains to allow comprehensive epidemiological and evolutionary studies.  
a. Collect samples from cows that were previously subjected to milk 
sampling. This will allow obtaining strains isolated from the same cow in 
different times, providing a unique and important set of data to study the 
bacterial evolution.  
b. Increase our culture collection with isolates originated from a wide range 
of herds, in order to assess biogeographical data.  
2) Develop an inverted dot blot platform with the most discriminatory markers. 
That will permit to simultaneously evaluate all the selected probes with a single 
hybridisation assay. 
3) Investigate more genes related to virulence factors and antimicrobials 
resistance. 
4) Standardize the clinical information gathered from infected cows, regarding 
severity, chronicity and resistance to treatment, in order to better assess the 
epidemiological features of the farms.  
5) Infer geographical and temporal dissemination patterns of streptococci causing 
bovine mastitis, and correlate these with bacterial genomic traits. 
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2. Figures, Graphs and Tables 
 
 
 
 
Figure 1:  Preliminary Dot blot assays of taxa-specific markers for Streptococcaceae (F1), Str. agalactiae 
(A1) in isolates. 
 
 
 
 
 
Figure 2: Dot blots of taxa-specific markers for Streptococcaceae (F1), Str. agalactiae (A1) and Str. uberis 
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Figure 3: Dot blots of virulence and functional markers from the hasC (V1), gapC (V2), oppF (V3), nisin U 
operon (NU1 and NU3), sua (sua) fructose operon (FO1 and FO3) and fbsB (fbsB) 
 
 
 
                                                                                                         
Figure 4: Dot blots of antimicrobials marker for ermB (V1). 
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Table I: Average probability values of the results obtained from the dot blot assays, with the respective 
herd and virulence genotype (VG). Values below 0.25 are indicated as red, values between 0.25 and 0.75 
as yellow and values above 0.75 are shown as green. 
Strain Herd VG 
Calculated probability for markers 
F1 A1 SU FO1 FO3 NU1 NU3 V1 V2 V3 sua fbsB ermB 
SA35 A 1 1 1 0,03 1 1 0 0,05 0 0,99 0,03 0,01 0,93 0,01 
SA36 A 1 0,98 1 0,02 1 1 0 0,04 0,01 0,97 0,02 0,01 0,79 0,01 
SA37 A 1 1 1 0,08 1 1 0 0,05 0,01 1 0,03 0,01 1 0,01 
SA38 A 1 1 1 0,04 1 1 0 0,02 0 0,93 0,02 0,01 0,82 0,01 
SA39 A 1 1 1 0,01 1 1 0 0,04 0 0,92 0,08 0,01 1 0,01 
SA40 A 2 1 1 0,08 1 1 0 0,04 0 0,72 0,08 0,01 0,98 0,01 
SA41 A 1 1 1 0,02 1 1 0 0,04 0 0,93 0,03 0,01 0,98 0 
SA42 A 1 1 1 0 1 1 0 0,03 0 0,87 0,02 0,01 1 0 
SA43 A 1 1 1 0 1 1 0,01 0,03 0 0,78 0,01 0,01 1 0 
SA44 A 1 1 1 0 1 1 0,02 0,02 0 0,79 0,01 0 0,99 0 
SA45 A 1 1 1 0,02 1 1 0,02 0,08 0 0,98 0,04 0,01 1 0 
SA46 A 1 1 1 0,01 1 1 0,02 0,07 0 0,98 0,02 0,01 0,95 0,01 
SA47 A 1 1 1 0,02 1 1 0,02 0,24 0,01 0,98 0,05 0,01 1 0,01 
SA48 A 1 1 0,98 0,13 1 1 0,02 0,09 0 0,98 0,03 0,01 1 0,01 
SA49 A 1 1 1 0,05 1 1 0,05 0,07 0,01 0,97 0 0,01 1 0,01 
SA50 A 1 1 1 0,05 1 1 0,02 0,05 0,01 0,95 0,04 0,01 1 0,02 
SA51 A 1 1 1 0,05 1 1 0,03 0,06 0 0,91 0,07 0 1 0 
SA52 A 3 1 1 0,03 1 1 0,04 0,07 0 0,11 0,01 0,01 1 0,01 
SA55 A 1 1 1 0,02 1 1 0,04 0,05 0 0,96 0,01 0,01 1 0,01 
SA56 A 1 1 1 0,02 1 1 0,02 0,04 0 0,82 0,02 0,01 1 0,01 
SA57 A 1 1 1 0,08 1 1 0,03 0,08 0,01 0,94 0,02 0,01 1 0,01 
SA58 A 1 1 1 0,02 1 1 0,04 0,12 0,02 1 0,13 0 1 0,03 
SA59 A 2 1 1 0,04 1 1 0,02 0,05 0,01 0,27 0,02 0,01 1 0,01 
SA60 A 1 1 1 0,04 1 1 0,01 0,1 0 0,86 0,02 0,01 1 0 
SA62 A 1 1 0,99 0,06 1 1 0,01 0,05 0 0,9 0,03 0,01 1 0,01 
SA65 A 1 1 1 0,05 1 1 0,01 0,05 0 0,91 0,03 0,01 1 0 
SA66 A 1 0,93 1 0 1 1 0,01 0,03 0 0,86 0,02 0,01 1 0 
SA67 A 2 1 1 0 1 1 0,02 0,05 0 0,58 0,02 0,01 1 0 
SA68 A 1 1 1 0,03 1 1 0,02 0,1 0 0,92 0,01 0,01 1 0 
SA69 A 1 1 1 0,02 1 1 0,05 0,06 0 0,98 0,01 0,02 1 0 
SA74 A 1 1 1 0,03 1 1 0,05 0,05 0 0,88 0,02 0,01 1 0 
SA76 B 2 1 1 0,17 1 1 0,03 0,04 0 0,64 0,01 0,01 1 0,01 
SA77 B 1 1 1 0,09 1 1 0,01 0,01 0 1 0,02 0,01 1 0,01 
SA78 B 1 1 0,99 0,01 1 1 0,01 0,02 0 0,94 0,02 0 1 0 
SA79 B 1 1 0,97 0,03 1 1 0,01 0,02 0 0,99 0,01 0 1 0 
SA80 B 1 1 1 0,02 0,98 1 0,02 0,01 0 0,97 0,02 0,01 1 0,01 
SA81 C 1 1 0,95 0 1 1 0,04 0,05 0 0,91 0 0 0,97 0,85 
SA82 C 1 0,98 0,96 0 1 1 0,01 0,05 0 0,99 0,01 0,01 1 0,7 
SA83 C 3 0,96 1 0,03 1 1 0,04 0,05 0 0 0,05 0,02 1 0,03 
SA84 C 1 1 1 0,03 1 1 0,02 0,04 0 0,92 0,01 0,03 1 0,97 
SA85 C 1 1 1 0,05 1 1 0,02 0,06 0 0,78 0 0,03 1 0,65 
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Table 1 (Continued) 
Strain Herd VG 
Calculated probability for markers 
F1 A1 SU FO1 FO3 NU1 NU3 V1 V2 V3 sua fbsB ermB 
SA86 C 1 1 1 0,26 1 1 0,01 0,02 0,01 0,99 0,04 0,01 1 0,01 
SA87 C 1 1 1 0,13 1 0,98 0,02 0,04 0 0,97 0,03 0,01 1 1 
SA88 C 1 1 1 0,06 1 1 0,01 0,04 0 1 0,02 0,01 1 1 
SA89 C 1 1 1 0,07 1 1 0,01 0,04 0 0,93 0,03 0 0,98 0,99 
SA90 A 1 1 1 0,03 1 1 0 0,04 0 0,83 0,02 0 1 0,01 
SA91 D 1 1 1 0,19 1 1 0,03 0,08 0,01 0,94 0,05 0 1 0,02 
SA92 D 1 1 1 0,05 1 1 0,03 0,07 0 1 0,08 0,01 1 0,03 
SA93 E 3 1 1 0,02 1 1 0 0,02 0 0,04 0,01 0 1 0 
SA94 E 2 0,95 0,95 0 1 1 0,02 0,01 0 0,5 0,02 0,01 0,84 0 
SA95 F 1 0,99 0,98 0,03 1 0,99 0,01 0,05 0 0,9 0,03 0,01 1 0,02 
SA96 F 1 1 0,99 0 1 1 0,01 0,01 0 0,92 0,04 0 1 0 
SA97 F 1 1 1 0 1 1 0 0,01 0 0,95 0,04 0,01 1 0,01 
SA98 F 1 0,98 1 0 1 1 0,01 0,02 0 0,91 0 0,01 1 0 
SA99 F 1 1 1 0 1 1 0,01 0,04 0 0,92 0,01 0,01 1 0,02 
SA100 G 2 1 1 0,03 0,97 1 0,01 0,03 0 0,46 0,01 0,01 1 0,01 
SA101 G 1 1 1 0,23 1 0,98 0,02 0,02 0 0,79 0,01 0,04 1 0,01 
SA102 G 1 0,95 1 0,04 1 1 0,01 0,02 0 0,76 0 0,01 1 0 
SA103 G 1 1 1 0,15 1 1 0,01 0,05 0 0,92 0,03 0,01 1 0,02 
SU10 J 10 1 0 1 0,13 0,2 0,04 0,6 0,99 1 1 1 0,01 1 
SU11 H 10 1 0 1 0,14 0,12 0,01 0,5 1 1 1 1 0,02 1 
SU13 H 8 1 0 1 0,24 0,29 0,04 0,72 1 1 1 1 0,03 1 
SU14 I 10 1 0 1 0,16 0,13 0,03 0,33 0,96 1 1 1 0,01 1 
SU15 J 9 1 0,01 1 0,17 0,2 1 1 0,88 1 1 0,95 0,01 1 
SU16 E 6 1 0,01 0,99 0,26 0,23 0,03 0,37 0,95 1 1 1 0,01 1 
SU17 E 5 1 0,01 1 0,29 0,27 0,03 0,48 1 1 1 1 0,01 0,97 
SU18 H 7 1 0,01 1 0,25 0,35 1 1 1 1 1 1 0,01 1 
SU19 K 5 1 0,01 1 0,36 0,5 0,04 0,75 1 1 1 1 0,01 1 
SU20 J 4 1 0,01 1 0,6 0,61 1 1 1 1 1 1 0,03 1 
 
 
